Accession Number: | 0001127602-19-027858 |
Date: | 2019-09-01 |
Issuer: | BIOCRYST PHARMACEUTICALS INC (BCRX) |
Original Submission Date: |
INGRAM ROBERT ALEXANDER
280 S. MANGUM STREET
SUITE 350
DURHAM, NC 27701
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-09-01 | A | 6,270 | a | $2.99 | 28,088 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | shares of common stock issued to the reporting person in lieu of quarterly cash board member retainer of $18,750. |